Particularly, rAAV9 seemed to be more effective in terms of heart transduction efficiency and was successfully used to treat cardiomyopathy in neonatal and adult mdx mice using micro-dystrophin [107,109,152]. This evidence concerns the gene DMD and cardiomyopathy.